Research Enterprise to Advance a Cure for HIV (REACH)

The REACH study, a NIH-funded consortium, promotes collaboration among researchers on HIV persistence and cure strategies, with the Rakai Health Sciences Program running a cohort of 90 HIV-positive individuals to study viral persistence from an African perspective, revealing insights into reservoir sizes and the impact of Dolutegravir, supported by onsite technology transfer for advanced analysis.

Join us in our mission to advance health research and improve public health outcomes globally.

Collaborate for Health, Innovate for Impact.